Figure 3From: Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009Composition of non-lamivudine component of nucleoside reverse transcriptase inhibitor and non-nucleoside reverse transcriptase inhibitor in the initial ART regimen among HIV-infected patients in the East Africa IeDEA Consortium, stratified by time and country. First regimen is missing in 1879/48, 658 (4%).Back to article page